Mesenchymal stem cell exosomes for peritoneal dialysis problems
This study tests whether exosomes from stem cells, given through the dialysis fluid, can help people on peritoneal dialysis whose dialysis isn't removing enough fluid. This may help reduce swelling and other symptoms of fluid overload.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been on continuous peritoneal dialysis for more than 1 year.
- You are at least 18 years old.
- Your dialysis doesn't remove enough fluid, as shown by specific test results or symptoms like swelling or heart failure.
- You don't have conditions like cancer, active infections, severe liver disease, or serious heart failure.
- You haven't had peritonitis in the past 3 months and don't have it now.
- You are not pregnant or planning pregnancy, and you're not in another drug trial.
- Your peritoneal dialysis catheter is working properly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a therapy made from stem cells (called MSC-EVs) can help patients recover from severe liver failure after a liver transplant. It is for people who had a sudden worsening of chronic liver disease and needed a new liver.
This trial tests whether a type of stem cell therapy can help people with chronic kidney disease caused by diabetes or high blood pressure. It aims to see if the treatment is safe and can slow kidney damage.
This trial tests a new treatment using stem cell-derived exosomes (tiny particles that help cells communicate) to heal diabetic foot ulcers. It aims to see if this approach is safe and effective for people with diabetic foot.
This trial studies whether a natural substance called exosomes, derived from stem cells, can help reduce pain and improve function in people with knee osteoarthritis. It may be an option if other treatments have not worked well for you.
This trial studies an infusion made from stem cells (called exosomes) to help people who develop failure in multiple organs after emergency surgery for a specific type of aortic tear. It aims to improve organ recovery and overall outcomes after the operation.
This trial tests whether exosomes (tiny particles) from human umbilical cord stem cells can help treat active ulcerative colitis. It is for people who have not responded well to standard treatments or cannot tolerate them.
Hear when a new Peritoneal Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.